TY  - JOUR
AU  - Lazcanoiturburu, Nerea
AU  - García‐Sáez, Juan
AU  - González‐Corralejo, Carlos
AU  - Roncero Romero, Cesáreo
AU  - Sanz Ortega, Julián
AU  - Martín‐Rodríguez, Carlos
AU  - Valdecantos, M Pilar
AU  - Martínez‐Palacián, Adoración
AU  - Almale Del Barrio, Laura
AU  - Bragado Domingo, Paloma
AU  - Calero‐Pérez, Silvia
AU  - Fernández, Almudena
AU  - García‐Bravo, María
AU  - Guerra, Carmen
AU  - Montoliu, Lluis
AU  - Segovia, José Carlos
AU  - Martínez Valverde, Ángela María
AU  - Fabregat Romero, María Isabel
AU  - Herrera González, Blanca María
AU  - Sánchez Muñoz, Aranzazu
PY  - 2022
DO  - 10.1002/path.6002
SN  - 0022-3417
SN  - 1096-9896
UR  - https://hdl.handle.net/20.500.14352/107028
T2  - Journal of Pathology
AB  - Despite the well‐known hepatoprotective role of the epidermal growth factor receptor (EGFR) pathway upon acute damage, its specific actions during chronic liver disease, particularly cholestatic injury, remain ambiguous and unresolved. Here, we...
LA  - eng
PB  - Wiley
KW  - EGFR
KW  - transgenic mouse
KW  - DDC diet
KW  - cholestasis
KW  - liver disease
KW  - regeneration
KW  - inflammation
KW  - ductular reaction
KW  - hepatic progenitor cell
TI  - Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response
TY  - journal article
ER  -